The cycling giant's reputation continues to be dogged by drug accusations. Discussing the possible impact on his endorsement empire, with CNBC's Darren Rovell.
Data is a real-time snapshot *Data is delayed at least 15 minutes Market Data Terms of Service
Global Business and Financial News, Stock Quotes, and Market Data and Analysis
More Comments
ADD COMMENTS
PREVIEW COMMENT